Correlation Between SCANDMEDICAL SOLDK-040 and Diageo Plc

Can any of the company-specific risk be diversified away by investing in both SCANDMEDICAL SOLDK-040 and Diageo Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANDMEDICAL SOLDK-040 and Diageo Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SCANDMEDICAL SOLDK 040 and Diageo plc, you can compare the effects of market volatilities on SCANDMEDICAL SOLDK-040 and Diageo Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANDMEDICAL SOLDK-040 with a short position of Diageo Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANDMEDICAL SOLDK-040 and Diageo Plc.

Diversification Opportunities for SCANDMEDICAL SOLDK-040 and Diageo Plc

-0.15

Correlation Coefficient

SCANDMEDICAL SOLDK-040  Diageo Plc

Good diversification

The 3 months correlation between SCANDMEDICAL and Diageo is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding SCANDMEDICAL SOLDK 040 and Diageo plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diageo plc and SCANDMEDICAL SOLDK-040 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANDMEDICAL SOLDK 040 are associated (or correlated) with Diageo Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diageo plc has no effect on the direction of SCANDMEDICAL SOLDK-040 i.e., SCANDMEDICAL SOLDK-040 and Diageo Plc go up and down completely randomly.

Pair Corralation between SCANDMEDICAL SOLDK-040 and Diageo Plc

Assuming the 90 days horizon SCANDMEDICAL SOLDK 040 is expected to under-perform the Diageo Plc. In addition to that, SCANDMEDICAL SOLDK-040 is 1.02 times more volatile than Diageo plc. It trades about -0.04 of its total potential returns per unit of risk. Diageo plc is currently generating about 0.07 per unit of volatility. If you would invest  2,935  in Diageo plc on October 8, 2024 and sell it today you would earn a total of  52.00  from holding Diageo plc or generate 1.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	94.12%
Values	Daily Returns

SCANDMEDICAL SOLDK 040  vs.  Diageo plc

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SCANDMEDICAL SOLDK-040 is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Diageo plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Diageo plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Diageo Plc is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with SCANDMEDICAL SOLDK-040 and Diageo Plc

The main advantage of trading using opposite SCANDMEDICAL SOLDK-040 and Diageo Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANDMEDICAL SOLDK-040 position performs unexpectedly, Diageo Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diageo Plc will offset losses from the drop in Diageo Plc's long position.

The idea behind SCANDMEDICAL SOLDK 040 and Diageo plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.